Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2020 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| NRA-CLOPIDOGREL | nora pharma inc | Marketed | Mar 5, 2020 | Marketed |
| PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI | Pharmascience Inc | Marketed | Mar 5, 2020 | Marketed |
| ROZLYTREK | Hoffmann-La Roche Limited | Marketed | Mar 4, 2020 | Marketed |
| HEMOSATE ULTRA HS2150 | chief medical supplies ltd | Marketed | Mar 4, 2020 | Marketed |
| SKIN LONG-WEAR FLUID POWDER FOUNDATION SPF 20 | dist. bobbi brown professional cosmetics | Cancelled Post Market | Mar 2, 2020 | Cancelled Po... |
| CLEAR COMPLEXION SHEER DAILY MOISTURIZER | johnson & johnson inc | Cancelled Post Market | Mar 2, 2020 | Cancelled Po... |
| LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP | hikma canada limited | Dormant | Mar 2, 2020 | Dormant |
| PDQ SCENTLESS DISINFECTANT CLEANER | MEGA-LAB MANUFACTURING CO LTD | Marketed | Mar 1, 2020 | Marketed |
| PDQ DISINFECTANT CLEANER | MEGA-LAB MANUFACTURING CO LTD | Dormant | Mar 1, 2020 | Dormant |
| SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L'ÂGE COMBINATION OILY TO OILY / MIXTE À GRASSE SPF 25 FPS | clinique laboratories dist | Marketed | Mar 1, 2020 | Marketed |
| SUPERDEFENSE CITY BLOCK DAILY ENERGY + FACE PROTECTOR SPF 50 | clinique laboratories dist | Marketed | Mar 1, 2020 | Marketed |
| SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L'ÂGE VERY DRY TO DRY COMBINATION / TRÈS SÈCHE À MIXTE SPF 25 FPS | clinique laboratories dist | Marketed | Mar 1, 2020 | Marketed |
| GLN-OLMESARTAN HCTZ | GLENMARK PHARMACEUTICALS CANADA INC. | Marketed | Feb 28, 2020 | Marketed |
| AG-CYCLOBENZAPRINE | angita pharma inc. | Marketed | Feb 28, 2020 | Marketed |
| METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Marketed | Feb 28, 2020 | Marketed |
| METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Marketed | Feb 28, 2020 | Marketed |
| METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Marketed | Feb 28, 2020 | Marketed |
| GLN-OLMESARTAN HCTZ | glenmark pharmaceuticals canada inc. | Marketed | Feb 28, 2020 | Marketed |
| METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Marketed | Feb 28, 2020 | Marketed |
| GLN-OLMESARTAN HCTZ | glenmark pharmaceuticals canada inc. | Marketed | Feb 28, 2020 | Marketed |
